C4X Discovery Holdings plc (C4XD.L)

12.00 +2.57 (+27.32%) At close: 05:38PM BST

C4X Discovery Holdings plc

Manchester One
53 Portland Street
Manchester M1 3LD
United Kingdom
44 1612 355 085
https://www.c4xdiscovery.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 49

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Clive James Dix B.Sc., Ph.D.	Interim Executive Chairman & CEO	211k	N/A	1954
Mr. Bradley Richard Hoy	CFO, Secretary & Executive Director	242k	N/A	1962
Ms. Bhavna Hunjan	Chief Business Officer & Executive Director	218k	N/A	1985
Ms. Emma Blaney Ph.D.	Chief Operating Officer	N/A	N/A	N/A
Dr. Nick Ray Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Dr. Clare Murray Ph.D.	Senior Vice President of Drug Discovery	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.

Corporate governance

C4X Discovery Holdings plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.